Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06302621
Status:
RECRUITING
Last Update Posted:
2024-04-26
First Post:
2022-08-10
Brief Title:
Pemigatinib Afatinib in Advanced Refractory Solid Tumors
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Organization Data
Organization:
Massachusetts General Hospital
Class:
OTHER
Study ID:
21-725
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Massachusetts General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Andreas Varkaris MD PhD
Responsible Party Title:
Instructor of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Massachusetts General Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Boehringer Ingelheim | INDUSTRY |
| Incyte Corporation | INDUSTRY |